Cell-Killing Protein Offers Hope for Defeating Cancer, Diabetes
By wchung | 02 Apr, 2026
A team of Australian scientists published their findings on the workings of a protein that kills cells in Monday’s issue of the journal Nature. Their work raises hope of developing drugs that can zero in on cells that cause cancer and other immune system disorders.
The protein perforin has been revealed to be the body’s defense against rogue cells that have become cancerous or hijacked by viruses by punching holes into the cells to allow toxic enzymes to invade and destroy them. This work is deemed a major advance in the field of immunology. By uncovering the precise mechanism of perforin, researchers will be able to focus their efforts on more effective and targeted ways to defeat diseases like cancer and malaria, and even disorders like diabetes.
The findings are the fruits of 10 years of collaboration between a team headed by Professor James Whisstock, an Australian Research Council Federation fellow at Monash University, a second Australian team at the Peter McCallum Cancer Institute in Melbourne, and scientists at Birkbeck College in London of Britain.
CANBERRA
Articles
- Investors See Trump Speech As Extending Hormuz Closure
- Sahra Nguyen Brought Vietnamese Coffee to America
- Trump to Declare Victory on Prime Time
- NASA Launches First Crewed Mission in Half Century
- Intel CEO Lip-Bu Tan to Pump More Millions into AI Startup SambaNova
- Senator Andy Kim Rejects Democrats' "Straight White Christian Male" Strategy
- Why So Many More AF/WM Couples than AM/WF Couples in the US?
- Trump Attends Supreme Court Hearing on Birthright Citizenship
- Nvidia's Dominance in China Erodes As Domestic Chipmakers Enjoy Bigger Share of AI Boom
- Tesla Car Registrations Soared in Key European Markets in Turnaround
